Press Releases Latest Investor Presentation More information is coming soon. Keyword Search Year None2021202020192018201720162015201420132012201120102009200820072006 Mar 18, 2021 Idera Pharmaceuticals Announces Results From ILLUMINATE-301 Trial of Tilsotolimod + Ipilimumab in anti-PD-1 Refractory Advanced Melanoma Read More Mar 01, 2021 Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update Read More Jan 11, 2021 Idera Pharmaceuticals to Present at Upcoming Conferences Read More
Mar 18, 2021 Idera Pharmaceuticals Announces Results From ILLUMINATE-301 Trial of Tilsotolimod + Ipilimumab in anti-PD-1 Refractory Advanced Melanoma Read More
Mar 01, 2021 Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update Read More
